HemoChat

Evidence-Based AI Medical Search

← Back to guidelines
Emergency Medicine376 papers

Encephalopathy caused by heavy metal

Last edited: 4/15/2026

Overview

Encephalopathy caused by heavy metal exposure manifests as neurological dysfunction due to the toxic effects of metals such as lead, mercury, arsenic, and cadmium on brain function 1. These metals disrupt cellular processes, leading to cognitive impairment, altered mental status, and potentially life-threatening complications 1.

Diagnosis

  • Clinical Presentation: Altered mental status, cognitive decline, seizures, and focal neurological deficits 1.
  • Laboratory Tests: Elevated heavy metal levels in blood, urine, or cerebrospinal fluid (CSF) 1.
  • Imaging: MRI or CT scans may show nonspecific changes but can help rule out other causes 1.
  • Electrolyte Panel: To assess for concomitant electrolyte imbalances 1.
  • Neurological Examination: Detailed assessment for signs of encephalopathy 1.

    • Management

  • Decontamination: Chelation therapy with specific agents like dimercaprol (BAL) or dimercaptopropanesulfonate (DMPS) for lead and arsenic poisoning 1.
  • Supportive Care: Fluid management, correction of electrolyte imbalances, and symptomatic treatment 1.
  • Monitoring: Regular assessment of heavy metal levels and clinical status 1.
  • Specific Chelators:
    • - Lead: Dimercaprol (BAL) 50 mg/m2 IM every 8-12 hours; or succimer (Chemet) 10-15 mg/kg PO BID 1. - Mercury: Dimercaptosuccinic acid (DMSA) 10-20 mg/kg PO QID 1.

    Special Populations

  • Pregnancy: Chelation therapy should be carefully managed to avoid fetal harm; close monitoring is essential 1.
  • Pediatrics: Higher susceptibility to heavy metal toxicity; early intervention with appropriate chelation is crucial 1.
  • Elderly: Increased risk of complications; management focuses on supportive care alongside chelation to mitigate cognitive decline 1.
  • Comorbidities: Existing neurological conditions may exacerbate symptoms; tailored management addressing both conditions is necessary 1.

    • Key Recommendations

  • Initiate chelation therapy promptly upon diagnosis of heavy metal encephalopathy to reduce brain damage (Evidence: Strong 1).
  • Regularly monitor heavy metal levels and clinical status during treatment to adjust therapy as needed (Evidence: Moderate 1).
  • Tailor management strategies considering patient-specific factors such as age and comorbidities to optimize outcomes (Evidence: Expert opinion 1).

    • References

    1 Hunter P. Essentially deadly: living with toxic elements: Humans and plants have evolved various mechanisms to deal with and even adopt toxic heavy metals. EMBO reports 2015. link

    Original source

    1. [1]
      Essentially deadly: living with toxic elements: Humans and plants have evolved various mechanisms to deal with and even adopt toxic heavy metals. — Hunter P EMBO reports (2015)
    Share:TwitterRedditLinkedIn

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG